TREATMENT-EMERGENT COVID-19 INFECTIONS IN OZANIMOD ULCERATIVE COLITIS AND MULTIPLE SCLEROSIS CLINICAL TRIALS

Authors
Category Primary study
JournalGastroenterology
Year 2022
This article has no abstract
Epistemonikos ID: f3325ce8f2a64013a200789784225d60395408e9
First added on: Feb 14, 2025